Genitourinary Cancers | Specialty

INTORSECT Trial: Second-Line Temsirolimus Versus Sorafenib

July 1st 2013

Determining Progression in Renal Cell Carcinoma

July 1st 2013

AXIS Trial: Second-Line Axitinib Versus Sorafenib

July 1st 2013

Frontline Sunitinib Compared to Everolimus in mRCC

July 1st 2013

Utilizing Frontline Bevacizumab in mRCC

July 1st 2013

AGILE Trial: Frontline Axitinib Versus Sorafenib in mRCC

July 1st 2013

PISCES Trial and Patient Treatment Preference in mRCC

July 1st 2013

COMPARZ Trial and Alternate Sunitinib Dosing Schedule

July 1st 2013

Introduction and Review of the COMPARZ Trial in RCC

July 1st 2013

Dr. Hutson on Tivozanib for Renal Cell Carcinoma

June 13th 2013

Thomas Hutson, DO, PharmD, discusses tivozanib for the treatment of advanced renal cell carcinoma (RCC).

Dr. Figlin on Sequencing mTOR Inhibitors and TKIs in RCC

June 12th 2013

Robert Figlin, MD, FACP, discusses the sequencing of mTOR inhibitors and tyrosine kinase inhibitors in renal cell carcinoma.

The Urology Center of Colorado: Raising the Bar for Collaborative Urologic Care

June 11th 2013

"If you build it, they will come," became a catchphrase thanks to the 1989 movie "Field of Dreams." For the founders of The Urology Center of Colorado (TUCC), it was more than just a saying.

FDA Rejects Tivozanib for Kidney Cancer, Recommends Additional Clinical Study

June 10th 2013

The FDA has rejected a new drug application for tivozanib for the treatment of advanced renal cell carcinoma, recommending an additional clinical trial to address concerns over existing clinical data.

Screening Remains Critical to Optimal Management of Prostate Cancer

May 28th 2013

The mortality rate from prostate cancer has declined significantly in the past few decades; however, there is much debate over how much PSA screening contributed to that decline.

Dr. Concepcion on Robotic Surgery Adverse Event Spikes

May 24th 2013

Raoul S. Concepcion, MD, from the Urology Associates, PC, Nashville, TN, discusses a recent FDA investigation into spikes in reported adverse events associated with the use of robotic-assisted surgery.

Dr. Deepak Kapoor Discusses PSA Screening Guidelines

May 22nd 2013

Deepak A. Kapoor, MD, president of the Large Urology Group Practice Association, provides his opinion on current prostate cancer screening recommendations.

Ablative Therapies for Small Renal Masses

May 22nd 2013

A peer-reviewed summary of the ablative techniques currently available for the treatment of small renal masses.

Early Results Robust for New PD-L1 Immunotherapy Agent

May 15th 2013

An antibody that targets PD-L1 to unleash the body's immune system has demonstrated a 21% response rate in a phase I study of patients with multiple solid tumors, setting the stage for an advance in immunotherapy with broad implications for treatment.

"Brothers in Arms"

May 7th 2013

We need to begin to migrate toward a system that embraces evidence-based medicine, and begin the development of protocols and the measurement of quality metrics.

Dramatic Shortage of Urologists on Horizon

May 6th 2013

An estimated 16,000 urologists will be needed to provide specialty care by 2025, but estimates of the number of urologists likely to be in practice at that time range between 6800 and 7400.